BSE filing, NSE: UNICHEMLAB. Summary written from the filing by ALFA Finder's alert engine.
Unichem Laboratories Ltd: key numbers
- Share price
- ₹490.00
- Market cap
- ₹3,450 Cr
- Revenue (annual)
- ₹2,202 Cr
- Net profit (annual)
- ₹252.8 Cr
- P/E (TTM)
- 11.3×Sector 46.5×
- Promoter holding
- 70.22%+0.00% QoQ
- FII holding
- 2.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Unichem Laboratories Ltd
All →Unichem Laboratories Board Meeting Date
Unichem Laboratories intimated that its Board will meet on November 4, 2026 to consider Q2 and H1 FY27 unaudited results. The meeting has not yet occurred.
Unichem Laboratories Other Announcement
Unichem Laboratories Limited submitted the quarterly compliance certificate under SEBI Regulation 74(5) as provided by its Registrar and Share Transfer Agent.
Unichem Laboratories Business Update
Unichem Laboratories received five procedural observations from the USFDA following an inspection of its Goa formulation facility. The company plans to respond within 15 days.
Unichem Laboratories Legal & Regulatory
Unichem Laboratories received a tax order from the Commissioner (Appeals, Thane) for a penalty and interest liability totaling ₹93.66 Crore. The company intends to file an appeal.
- Value
- ₹93.66 Cr
Unichem Laboratories Employee Stock Options
Unichem extended the exercise period for 3.75 lakh vested ESOP options from 30-Sep-2026 to 31-Mar-2027. The NRC approved the extension via circular resolution under the 2018 Scheme.
Unichem Laboratories Price Movement Clarification
Unichem Laboratories clarified that the recent spurt in trading volume is purely market-driven. The company confirmed it has no undisclosed price-sensitive information to report.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.